mTOR at the Transmitting and Receiving Ends in Tumor Immunity.

mTOR at the Transmitting and Receiving Ends in Tumor Immunity.
复制标题

DOI:
10.3389/fimmu.2018.00578
复制
发表时间:
2018
影响因子:
7.3
通讯作者:
Roszik J
Roszik J
中科院分区:
医学2区
文献类型:
--
作者:
Guri Y;Nordmann TM;Roszik J

文献摘要

参考文献

被引文献

相似文献

癌症是一种复杂的疾病,也是全球主要的死亡原因。免疫力对癌症控制至关重要。癌细胞表现出很高的突变率,因此改变了自身或新的抗原,引发免疫反应来促进肿瘤的根除。未能建立适当的免疫反应会导致癌症的进展。MTOR信号调控细胞代谢、免疫细胞分化和效应器功能。癌细胞中mTOR信号失控可调节肿瘤微环境,从而影响肿瘤免疫,并可能促进肿瘤的发生。
Cancer is a complex disease and a leading cause of death worldwide. Immunity is critical for cancer control. Cancer cells exhibit high mutational rates and therefore altered self or neo-antigens, eliciting an immune response to promote tumor eradication. Failure to mount a proper immune response leads to cancer progression. mTOR signaling controls cellular metabolism, immune cell differentiation, and effector function. Deregulated mTOR signaling in cancer cells modulates the tumor microenvironment, thereby affecting tumor immunity and possibly promoting carcinogenesis.
MTORC1的信号整合与生物合成输出相协调的营养输入。
DOI: 10.1038/ncb2763
发表时间: 2013-06
影响因子: 21.3
作者:
通讯作者: --
DOI: 10.1016/j.ccell.2017.02.008
发表时间: 2017-03-13
期刊: Cancer cell
影响因子: 50.3
作者:
Anderson KG;Stromnes IM;Greenberg PD
通讯作者: Greenberg PD
DOI: 10.1038/ni.2703
发表时间: 2013-10
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --
癌症相关成纤维细胞通过旁分泌信号调节肺癌干细胞的可塑性
DOI: 10.1038/ncomms4472
发表时间: 2014-03-01
影响因子: 16.6
作者:
Chen, Wan-Jiun;Ho, Chao-Chi;Yang, Pan-Chyr
通讯作者: Yang, Pan-Chyr
DOI: 10.1016/j.ccr.2009.01.001
发表时间: 2009-02-03
期刊: Cancer cell
影响因子: 50.3
作者:
Grivennikov S;Karin E;Terzic J;Mucida D;Yu GY;Vallabhapurapu S;Scheller J;Rose-John S;Cheroutre H;Eckmann L;Karin M
通讯作者: Karin M